Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00366990 · ClinicalTrials.gov registry record · NA
Low Sodium Diet and Behavioral Intervention for Reversing Arterial Stiffening in Overweight Individuals
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT00366990: Completed NA study, sponsored by University of Pittsburgh.
NCT00366990 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 349 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00366990, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
Obese individuals are at risk for developing cardiovascular disease (CVD). Increasing physical activity, losing weight, and reducing sodium intake may reverse arterial stiffness and blood vessel damage that is linked to obesity. This study will evaluate the effectiveness of a low sodium diet and a behavioral weight loss intervention in reducing arterial stiffness in overweight young adults.
Interventions
- BEHAVIORAL Low Sodium Diet
- BEHAVIORAL Regular Sodium Intake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2007-01 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00366990 record still lists
NCT00366990 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Sodium Diet is the first listed.
NCT00366990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00366990 about?
NCT00366990 is a clinical study titled "Low Sodium Diet and Behavioral Intervention for Reversing Arterial Stiffening in Overweight Individuals". Obese individuals are at risk for developing cardiovascular disease (CVD). Increasing physical activity, losing weight, and reducing sodium intake may reverse arterial stiffness and blood vessel damage that is linked to obesity. This study will evaluate the effectiveness of a low sodium diet and a b...
What is the current status of trial NCT00366990?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2007-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00366990?
The interventions under investigation include: Low Sodium Diet (BEHAVIORAL), Regular Sodium Intake (BEHAVIORAL).
Who is sponsoring clinical trial NCT00366990?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00366990's enrollment target sits among peer trials
349 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia